US 9315568
Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders
granted A61KA61K31/519A61K38/00
Quick answer
US patent 9315568 (Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders) held by ADHERON THERAPEUTICS, INC. expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ADHERON THERAPEUTICS, INC.
- Grant date
- Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/519, A61K38/00, A61K39/3955, A61K45/06